会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 59. 发明授权
    • Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications
    • 多药耐药相关蛋白1(MRP-1)的人类基因多态性及其在诊断和治疗应用中的应用
    • US08039211B2
    • 2011-10-18
    • US11901238
    • 2007-09-13
    • Ulrich BrinkmannSven HoffmeyerEsther Mornhinweg
    • Ulrich BrinkmannSven HoffmeyerEsther Mornhinweg
    • C12Q1/68C12P19/34
    • C12Q1/6883C07K14/47C12Q2600/106C12Q2600/156C12Q2600/158G01N33/6893G01N2333/705G01N2500/04G01N2800/44
    • The present invention relates to a polymorphic MRP-1 polynucleotide. Moreover, the invention relates to genes or vectors comprising the polynucleotides of the invention and to a host cell genetically engineered with the polynucleotide or gene of the invention. Further, the invention relates to methods for producing molecular variant polypeptides or fragments thereof, methods for producing cells capable of expressing a molecular variant polypeptide and to a polypeptide or fragment thereof encoded by the polynucleotide or the gene of the invention or which is obtainable by the method or from the cells produced by the method of the invention. Furthermore, the invention relates to an antibody which binds specifically the polypeptide of the invention. Moreover, the invention relates to a transgenic non-human animal. The invention also relates to a solid support comprising one or a plurality of the above mentioned polynucleotides, genes, vectors, polypeptides, antibodies or host cells. Furthermore, methods of identifying a polymorphism, identifying and obtaining a pro-drug or drug or an inhibitor are also encompassed by the present invention. In addition, the invention relates to methods for producing of a pharmaceutical composition and to methods of diagnosing a disease. Further, the invention relates to a method of detection of the polynucleotide of the invention. Furthermore, comprised by the present invention are a diagnostic and a pharmaceutical composition. Even more, the invention relates to uses of the polynucleotides, genes, vectors, polypeptides or antibodies of the invention. Finally, the invention relates to a diagnostic kit.
    • 本发明涉及多形性MRP-1多核苷酸。 此外,本发明涉及包含本发明的多核苷酸的基因或载体,并涉及用本发明的多核苷酸或基因进行遗传工程改造的宿主细胞。 此外,本发明涉及用于产生分子变体多肽或其片段的方法,用于产生能够表达分子变体多肽的细胞的方法及其由本发明的多核苷酸或基因编码的多肽或其片段,或可由 方法或由本发明方法生产的细胞。 此外,本发明涉及特异性结合本发明多肽的抗体。 此外,本发明涉及转基因非人动物。 本发明还涉及包含一种或多种上述多核苷酸,基因,载体,多肽,抗体或宿主细胞的固体支持物。 此外,鉴定多态性,鉴定和获得前药或药物或抑制剂的方法也包括在本发明中。 此外,本发明涉及制备药物组合物的方法和诊断疾病的方法。 此外,本发明涉及本发明的多核苷酸的检测方法。 此外,本发明包括诊断和药物组合物。 更进一步地,本发明涉及本发明的多核苷酸,基因,载体,多肽或抗体的用途。 最后,本发明涉及诊断试剂盒。